Preferred Label : ornithine;

MeSH definition : An amino acid produced in the urea cycle by the splitting off of urea from arginine.;

CISMeF synonym : 70-26-8 (Ornithine, (L)-Isomer); 2,5-diaminopentanoic acid; ornithine, (L)-Isomer;

MeSH hyponym : Ornithine Monoacetate, (L)-Isomer; Ornithine Monohydrochloride, (DL)-Isomer; ornithine hydrochloride, (DL)-Isomer; Ornithine Sulfate (1:1), (L)-Isomer; Ornithine Monohydrochloride, (D)-Isomer; Ornithine Monohydrobromide, (L)-Isomer; Ornithine Dihydrochloride, (L)-Isomer; ornithine, (DL)-Isomer; ornithine, (D)-Isomer; ornithine hydrochloride, (D)-Isomer; ornithine phosphate (1:1), (L)-Isomer; ornithine hydrochloride, (L)-Isomer; 2,5 Diaminopentanoic Acid;

MeSH CAS label : ornithine;

MeSH Related Number : ornithine, (D)-Isomer; ornithine, (DL)-Isomer; ornithine dihydrochloride, (L)-Isomer; ornithine monohydrobromide, (L)-Isomer; ornithine hydrochloride, (D)-Isomer; ornithine hydrochloride, (DL)-Isomer; ornithine hydrochloride, (L)-Isomer; ornithine monoacetate, (L)-Isomer; ornithine monohydrochloride, (D)-Isomer; ornithine monohydrochloride, (DL)-Isomer; ornithine phosphate (1:1), (L)-Isomer; ornithine sulfate (1:1), (L)-Isomer; 1069-31-4 ((DL)-isomer, mono-HCl); 16682-12-5 ((D)-isomer, mono-HCl); 20724-48-5 ((L)-isomer, HCl); 22834-83-9 ((DL)-isomer, HCl); 3184-13-2 ((L)-isomer, mono-HCl); 348-66-3 ((D)-isomer); 44805-33-6 ((L)-isomer, mono-HBr); 60259-81-6 ((L)-isomer, monoacetate); 616-07-9 ((DL)-isomer); 6211-16-1 ((L)-isomer, di-HCl); 70-26-8 ((L)-isomer); 7006-33-9 (Ornithine); 77208-15-2 ((L)-isomer, phosphate (1:1)); 93803-21-5 ((L)-isomer, sulfate (1:1)); 99815-05-1 ((D)-isomer, HCl);

Registry Number MeSH : 7006-33-9;

Related CAS MeSH : 99815-05-1 (Ornithine hydrochloride, (D)-Isomer); 22834-83-9 (Ornithine hydrochloride, (DL)-Isomer); 20724-48-5 (Ornithine hydrochloride, (L)-Isomer); 60259-81-6 (Ornithine monoacetate, (L)-Isomer); 16682-12-5 (Ornithine monohydrochloride, (D)-Isomer); 1069-31-4 (Ornithine monohydrochloride, (DL)-Isomer); 77208-15-2 (Ornithine phosphate (1:1), (L)-Isomer); 93803-21-5 (Ornithine sulfate (1:1), (L)-Isomer); 348-66-3 (Ornithine, (D)-Isomer); 616-07-9 (Ornithine, (DL)-Isomer); 6211-16-1 (Ornithine dihydrochloride, (L)-Isomer); 44805-33-6 (Ornithine monohydrobromide, (L)-Isomer);

MeSH annotation : /biosyn /physiol permitted;

Wikipedia link : https://en.wikipedia.org/wiki/Ornithine;

Is substance : O;

medicament (CISMeF) : O;

UNII : E524N2IXA3;

InChIKey : AHLPHDHHMVZTML-BYPYZUCNSA-N;

Details


Main resources

You can consult :

An amino acid produced in the urea cycle by the splitting off of urea from arginine.

https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-des-erreurs-innees-du-metabolisme.html
2019
false
false
false
Canada
infant, newborn
canada
Methylcrotonyl-CoA Carboxylase Deficiency
hyperargininemia
HHH syndrome
CTNL1
neonatal-onset citrullinemia type 2
methylmalonic acidemia
propionic acidemia
health technology assessment
tandem mass spectrometry
metabolism, inborn errors
mass screening
inborn errors of metabolism screen
ornithine
ornithine
hyperammonemia
urea cycle disorders, inborn
citrullinemia
amino acid metabolism, inborn errors

---
https://www.has-sante.fr/portail/jcms/c_2855997/fr/ravicti
https://www.has-sante.fr/portail/jcms/c_2855997/fr/ravicti-phenylbutyrate-de-glycerol-medicament-des-voies-digestives-et-du-metabolisme
2018
false
false
false
France
French
treatment outcome
glycerol phenylbutyrate
glycerol phenylbutyrate
urea cycle disorders, inborn
adult
adolescent
child
infant
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
argininosuccinic aciduria
hyperargininemia
citrullinemia
HHH syndrome
administration, oral
Enteral Route of Administration
Gastroenteral route (qualifier value)
evaluation of the transparency committee
guidelines for drug use
ornithine
hyperammonemia
phenylbutyrates
glycerol
glycerol

---
https://www.ema.europa.eu/medicines/human/EPAR/Ravicti
2015
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
orphan drug production
glycerol phenylbutyrate
glycerol phenylbutyrate
glycerol phenylbutyrate
urea cycle disorders, inborn
adult
adolescent
child
infant
carbamoyl-phosphate synthase i deficiency disease
ornithine carbamoyltransferase deficiency disease
argininosuccinic aciduria
hyperargininemia
citrullinemia
HHH syndrome
continuity of patient care
administration, oral
Enteral Route of Administration
product surveillance, postmarketing
Gastroenteral route (qualifier value)
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
ornithine
hyperammonemia
phenylbutyrates
glycerol
glycerol
phenylbutyrates
glycerol

---
http://www.has-sante.fr/portail/jcms/c_2572469/fr/cetornan
http://www.has-sante.fr/portail/jcms/c_2572469/fr/cetornan-5-g-ornithine-therapeutique-hepatique
http://www.has-sante.fr/portail/jcms/c_939180/cetornan
http://www.has-sante.fr/portail/jcms/c_400298/fr/cetornan-5-g-poudre-pour-solution-buvable-et-solution-enterale-en-sachet-10-sachet-s-papier-aluminium-polyethylene-de-5-g-code-cip-330-278-2
2015
false
false
false
false
France
French
evaluation of the transparency committee
ornithine alpha-ketoglutarate
guidelines for drug use
drugs, generic
aged
administration, oral
enteral nutrition
malnutrition
treatment outcome
insurance, health, reimbursement
ornithine
ornithine

---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=109637&nom=Ornithine+(l-)
Canada
toxicological data sheet
ornithine

---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=52498&nom=Ornithine+(l-),+monochlorhydrate+de
Canada
toxicological data sheet
ornithine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68586438
2012
France
summary of product characteristics
package leaflet
powders
ornithine alpha-ketoglutarate
ornithine

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65954835
2012
France
summary of product characteristics
package leaflet
ornithine
powders
ornithine alpha-ketoglutarate

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64349947
2012
France
summary of product characteristics
package leaflet
ornithine
ornithine alpha-ketoglutarate
powders

---
http://www.has-sante.fr/portail/display.jsp?id=c_400532
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct032109.pdf
2005
France
French
administration, oral
drug combinations
betaine
drugs for bile therapy and lipotropics in combination
magnesium carbonate
magnesium
ornithine
citric acid
sorbitol
treatment outcome
dyspepsia
magnesium
evaluation of the transparency committee

---
Nous contacter.
23/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.